Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998

被引:99
作者
Tanaka, M
Nakayama, H
Haraoka, M
Saika, T
Kobayashi, I
Naito, S
机构
[1] Kyushu Univ, Fac Med, Dept Urol, Higashi Ku, Fukuoka 8128582, Japan
[2] Nakayama Urol Clin, Fukuoka, Japan
[3] Mitsubishi Kagaku BCL, Chemotherapy Div, Tokyo, Japan
关键词
D O I
10.1128/JCM.38.2.521-525.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To assess the antimicrobial resistance of Neisseria gonorrhoeae isolated from 1993 through 1998 in Japan, susceptibility testing was conducted on 502 isolates. Selected isolates were characterized by auxotype and analysis for mutations within the quinolone resistance-determining region (QRDR) in the gyrA and parC genes, which confer fluoroquinolone resistance on the organism. Plasmid-mediated penicillin resistance (penicillinase-producing N, gonorrhoeae) decreased significantly from 1993-1994 (7.9%) to 1997-1998 (2.0%). Chromosomally mediated penicillin resistance decreased from 1993-1994 (12.6%) to 1995-1996 (1.9%) and then increased in 1997-1998 (10.7%). Chromosomally mediated tetracycline resistance decreased from 1993-1994 (3.3%) to 1997-1998 (2.0%), and no plasmid-mediated high-level tetracycline resistance was found. Isolates with ciprofloxacin resistance (MIC greater than or equal to 1 mu g/ml) increased significantly from 1993-1994 (6.6%) to 1997-1998 (24.4%). The proline-requiring isolates were less susceptible to ciprofloxacin than the prototrophic or arginine-requiring isolates. Ciprofloxacin-resistant isolates contained three or four amino acid substitutions within the QRDR in the GyrA and ParC proteins.
引用
收藏
页码:521 / 525
页数:5
相关论文
共 35 条
  • [1] NEISSERIA-GONORRHOEAE ACQUIRES MUTATIONS IN ANALOGOUS REGIONS OF GYRA AND PARC IN FLUOROQUINOLONE-RESISTANT ISOLATES
    BELLAND, RJ
    MORRISON, SG
    ISON, C
    HUANG, WM
    [J]. MOLECULAR MICROBIOLOGY, 1994, 14 (02) : 371 - 380
  • [2] ORAL CIPROFLOXACIN VERSUS CEFTRIAXONE FOR THE TREATMENT OF URETHRITIS FROM RESISTANT NEISSERIA-GONORRHOEAE IN ZAMBIA
    BRYAN, JP
    HIRA, SK
    BRADY, W
    LUO, N
    MWALE, C
    MPOKO, G
    KRIEG, R
    SIWIWALIONDO, E
    REICHART, C
    WATERS, C
    PERINE, PL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) : 819 - 822
  • [3] CATLIN BW, 1973, J INFECT DIS, V128, P178, DOI 10.1093/infdis/128.2.178
  • [4] Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P57
  • [5] Plasmid analysis of Neisseria gonorrhoeae isolates and dissemination of tetM genes in southern Africa 1993-1995
    Chalkley, LJ
    van Rensburg, MNJ
    Matthee, PC
    Ison, CA
    Botha, PL
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (06) : 817 - 822
  • [6] REDUCED UPTAKE OF CIPROFLOXACIN IN A RESISTANT STRAIN OF NEISSERIA-GONORRHOEAE AND TRANSFORMATION OF RESISTANCE TO OTHER STRAINS
    CORKILL, JE
    PERCIVAL, A
    LIND, M
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (04) : 601 - 604
  • [7] COMPARISON OF OFLOXACIN AND CEFTRIAXONE IN THE TREATMENT OF UNCOMPLICATED GONORRHEA CAUSED BY PENICILLINASE-PRODUCING AND NON-PENICILLINASE-PRODUCING STRAINS
    COVINO, JM
    CUMMINGS, M
    SMITH, B
    BENES, S
    DRAFT, K
    MCCORMACK, WM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (01) : 148 - 149
  • [8] Quinolone-resistant Neisseria gonorrhoeae: Correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles
    Deguchi, T
    Yasuda, M
    Nakano, M
    Ozeki, S
    Ezaki, T
    Saito, I
    Kawada, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) : 1020 - 1023
  • [9] DILLON JAR, 1989, CLIN MICROBIOL REV S, V2, P125
  • [10] Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: The emergence of decreased susceptibility to the fluoroquinolones
    Fox, KK
    Knapp, JS
    Holmes, KK
    Hook, EW
    Judson, FN
    Thompson, SE
    Washington, JA
    Whittington, WL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (06) : 1396 - 1403